KIT exon 11 mutation + KIT exon 17 mutation	Gastrointestinal Stromal Tumor	KIT exon 11 mutation + KIT exon 17 mutation	Gastrointestinal Stromal Tumor	nilotinib Sensitive: C3 – Early Trials nilotinib Sensitive : C3	nilotinib Sensitive: C3 – Early Trials nilotinib Sensitive : C3
KIT exon 11 mutation + KIT exon 17 mutation	Gastrointestinal Stromal Tumor	KIT exon 11 mutation + KIT exon 17 mutation	Gastrointestinal Stromal Tumor	sunitinib + IPI 493 Sensitive: D – Preclinical sunitinib + IPI 493 Sensitive : D	sunitinib + IPI 493 Sensitive: D – Preclinical sunitinib + IPI 493 Sensitive : D

KIT exon 11 mutation + KIT exon 17 mutation

Associations